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Abstract 
Background Intravenous thrombolysis (IVT)-ineligible patients undergoing direct thrombectomy tended to 
have poorer 
functional outcome as compared with IVT-eligible patients undergoing bridging therapy. We aimed to 
assess radiological 
and functional outcomes in large vessel occlusion-related stroke patients receiving direct thrombectomy in 
the presence of 
absolute exclusion criteria for IVT vs relative exclusion criteria for IVT and vs non-exclusion criteria for IVT. 
Methods A cohort study on prospectively collected data from 2282 patients enrolled in the Italian Registry 
of Endovascular 
Treatment in Acute Stroke cohort for treatment with direct thrombectomy (n=486, absolute exclusion 
criteria for IVT alone; 
n=384, absolute in combination with relative exclusion criteria for IVT; n=777, relative exclusion criteria for 
IVT alone; 
n=635, non-exclusion criteria for IVT). 
Results After adjustment for unbalanced variables (model 1), ORs for 3-month death was higher in the 
presence of absolute 
exclusion criteria for IVT alone (vs relative exclusion criteria for IVT alone) (1.595, 95% CI 1.042–2.440) and 
in the presence of absolute exclusion criteria for IVT alone (vs non-exclusion criteria for IVT) (1.235, 95% CI 
1.014–1.504). After 
adjustment for predefned variables (model 2: age, sex, pre-stroke mRS≤1, NIHSS, occlusion in the anterior 
circulation, 
onset-to-groin time, and procedure time), ORs for 3-month death was higher in the presence of absolute 
exclusion criteria 
for IVT alone (vs relative exclusion criteria for IVT alone) (1.235, 95% CI 1.014–1.504) and in the presence of 
absolute 
exclusion criteria for IVT alone (vs non-exclusion criteria for IVT) (1.246, 95% CI 1.039–1.495). No signifcant 
diference 
was found between the groups as regards any type of intracerebral hemorrhage and parenchymal 
hematoma within 24 h, 
successful and complete recanalization after procedure, and modifed Rankin Scale score 0–2 at 3 months. 
After adjustment 
for predefned variables of model 2, ORs for death were higher in the presence of recent administration of 
IV heparin (OR: 
2.077), platelet count<100,000/mm3 
 (OR: 4.798), bacterial endocarditis (OR: 15.069), neoplasm with increased hemorrhagic risk (OR: 6.046), 
and severe liver disease (OR: 6.124). 
Electronic supplementary material The online version of this 
article (https://doi.org/10.1007/s00415-020-10098-w) contains 
supplementary material, which is available to authorized users. 
Extended author information available on the last page of the article 
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Conclusions Radiological outcomes were similar after direct thrombectomy in patients with absolute, 
relative, and nonexclusion criteria for IVT, while an increase of fatal outcome was observed in the presence 
of some absolute exclusion 
criterion for IVT. 
Keywords Stroke · Thrombectomy · Thrombolysis · Outcome 
Introduction 
Mechanical thrombectomy for ischemic stroke with large vessel occlusion (LVO) substantially reduces 
disability with fve 
randomized clinical trials (RCTs) leading to guideline changes 
worldwide [1–5]. Direct thrombectomy is recommended 
within 6 h in the presence of contraindications to intravenous 
thrombolysis (IVT) listed in the current summary of product 
characteristics (SPC) of Actilyse and up to 16–24 h of last time 
known well in patients selected according to the clinical and 
radiological criteria of DEFUSE-3 and DAWN trials [6–8]. 
The experience accumulated over the years by centers performing IVT suggests that the use of Actilyse is 
efective and 
sufciently safe for ischemic stroke regardless of the presence 
of some contraindications listed in the SPC of the drug. Therefore, the current guidelines re-classifed the 
contraindications 
to the use of Actilyse into “absolute” or “relative exclusion 
criteria” for IVT [9]. Among three RCTs (i.e., MR CLEAN, 
ESCAPE, and REVASCAT) [1, 2, 5] including a total of 188 
patients (108 direct mechanical thrombectomy vs 80 controls) 
who were ineligible for IVT, only a MR CLEAN sub-analysis 
listed the specifc contraindications for Actilyse; however, data 
on outcome were not reported [10]. 
A recent meta-analysis reported that IVT-ineligible patients 
treated with direct mechanical thrombectomy tended to have 
lower rates of functional independence and had higher odds 
for fatal outcome, as compared with IVT-eligible patients 
treated with bridging therapy [11]. However, IVT-ineligible 
patients are inherently diferent from IVT-eligible patients, 
as suggested by of-label thrombolysis studies that reported 
a higher rate of sICH [12-14] and a higher rate of poor functional outcome and/or death [13, 15] in some 
absolute exclusion criterion for IVT. 
The aim of this study was to assess radiological and functional outcomes in LVO-related acute ischemic 
strokes treated 
with direct mechanical thrombectomy in the presence of absolute exclusion criteria for IVT vs relative 
exclusion criteria for 
IVT and vs non-exclusion criteria for IVT. 
Methods 
Study design, participants, and procedures 
We conducted a cohort study on prospectively collected data 
of patients enrolled in the Italian Registry of Endovascular 
Treatment in Acute Stroke (IRETAS). The IRETAS is a multicenter, observational internet-based registry 
(Supplemental Table 1). Acute ischemic stroke patients with LVO who 
received endovascular procedures between January 2011 and 
December 2017 were included in the present study. Participating centers were required to accept the rules 
of the IRETAS, including consecutive registration of all stroke patients 
receiving endovascular procedures irrespective of whether 
treatment was according to guidelines. 
Data collection 
Data collection is provided in the Supplemental Data. 
Inclusion and exclusion criteria 
We included all patients aged 18  years and older who 
received direct mechanical thrombectomy within 24 h from 
known symptom onset or symptom recognition time (for 
unwitnessed stroke) or awakening time (for wake-up stroke). 
We identifed the presence of absolute and relative exclusion 
criteria for IVT according to the current guidelines [9]. As 
regards time window for treatment, we defned arbitrarily 
the time between known symptom onset and endovascular 
treatment hospital admission as absolute exclusion criterion for IVT if it was>4.5 h. Given that recruitment 
largely 
preceded the evidence for mechanical thrombectomy in 
unknown onset strokes [7, 8], the choice of type of endovascular procedure for these patients was at the 
discretion of 
the neurologist and neuroradiologist. We defned arbitrarily 
unwitnessed stroke and wake-up stroke as absolute exclusion criteria for IVT if the symptom recognition 
time or 
awakening time were>4.5 h from endovascular treatment 
hospital admission. 
Outcome measures 
The radiological outcome measures were (a) any type of 
intracerebral hemorrhage (ICH) and (b) parenchymal hematoma (PH) within 24 h; (c) successful 
recanalization and d) 
complete recanalization after procedure defned as thrombolysis in cerebral infarction (TICI) grading system 
2b/3 
and 3, respectively. The functional outcome measures were 
(a) favorable functional outcome (mRS score 0–2) and (b) 
death at 3 months. 
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Statistical analysis 
We performed statistical analyses using SPSS 22.0 statistical package. Diferences between the cohorts were 
explored 
using the Mann–Whitney U test for continuous variables. 
Diferences between proportions were assessed by Fisher’s 
exact test or χ2 
 test, where appropriate. Continuous variables 
were reported as median and interquartile range (IQR) values. Proportions were calculated for categorical 
variables, 
dividing the number of events by the total number excluding 
missing/unknown cases. 
We estimated the association of the presence of absolute 
exclusion criteria for IVT alone (vs relative exclusion criteria for IVT alone, vs non-exclusion criteria for IVT) 
and 
the presence of relative exclusion criteria for IVT alone (vs 
non-exclusion criteria for IVT) with outcome measures by 
calculating the odds ratio (OR) with two-sided 95% confdence intervals (CI) after three adjustment models. 
Model 1 
included group diferences in baseline characteristics (probability value<0.10), model 2 included age, sex, 
pre-stroke 
mRS score<1, NIH Stroke Scale (NIHSS) score, symptom 
onset-to-groin puncture time, LVO in the anterior circulation 
and procedure time, model 3 included variables of model 
2 plus occlusion site and Alberta Stroke Program Early 
Computed Tomography (ASPECT) score≥6, type of procedure, additional intra-arterial (IA) fbrinolysis, and 
general 
anesthesia. Careggi collateral score did not enter the models because the number of missing values was 
greater than 
one-third of the entire cohort. 
Standard protocol approvals, registrations, 
and patient consents 
The need for ethical approval or patient consent for participation in the IRETAS varied among participating 
hospitals. 
Ethical approval and informed consent were obtained when 
required. 
Data availability statement 
Anonymized data will be shared by request from any qualifed investigator. 
Results 
Among 2737 patients registered in the IRETAS cohort by 44 
centers for treatment with direct mechanical thrombectomy 
(Supplemental Table 2), 2282 patients were included in the 
study. Flow diagram of patient inclusion and exclusion is 
provided in the Supplemental Data. Characteristics of the 
included and excluded patients are provided in Supplemental 
Table 3. 
Characteristics of the patients with (n=870) and without 
(n=1412) absolute exclusion criteria for IVT are provided 
in Table 1. Absolute exclusion criteria for IVT are listed in 
Table 2, while relative exclusion criteria for IVT are listed 
in Supplement Table 4. 
Absolute exclusion criteria for IVT alone were reported 
in 486 (21%) patients, absolute in combination with relative 
exclusion criteria for IVT in 384 (17%) patients, relative 
exclusion criteria for IVT alone in 777 (34%) patients, and 
non-exclusion criteria for IVT in 635 (28%) patients. 
Characteristics of the patients with absolute exclusion criteria for IVT alone, relative exclusion criteria for 
IVT alone, 
and non-exclusion criteria are provided in Table 3 
Associations of the presence of absolute exclusion criteria for IVT alone (vs relative exclusion criteria for IVT 
alone, vs non-exclusion criteria for IVT) and presence of 
relative exclusion criteria for IVT alone (vs non-exclusion 
criteria for IVT) with outcome measures after three adjustment models are provide in Table 4. ORs for 
death was 
higher in the presence of absolute exclusion criteria for IVT 
alone (vs relative exclusion criteria for IVT alone) in model 
1 (OR: 1.595, 95% CI 1.042–2.440) and in model 2 (OR: 
1.485, 95% CI 1.060–2.080). ORs for death was higher in 
the presence of absolute exclusion criteria for IVT alone 
(vs non-exclusion criteria for IVT) in model 1 (OR: 1.235, 
95% CI 1.014–1.504) and in model 2 (OR: 1.246, 95% CI 
1.039–1.495). We found no signifcant diference between 
the groups as regards any type of ICH and PH within 24 h, 
successful and complete recanalization after procedure, and 
favorable functional outcome at 3 months. 
In the unadjusted ordinal logistic regression and after 
adjustment for pre-defned variables of model 2 (age, sex, 
pre-stroke mRS≤1, NIHSS score, LVO in the anterior circulation, symptom onset-to-groin puncture time, and 
procedure 
time), beneft of successful recanalization (vs unsuccessful 
recanalization) on 3-month mRS (from 0 to 6) was similar 
in patients with absolute exclusion criteria for IVT alone 
(OR: 0.327, 95% CI 0.223–0.481; adjusted OR: 0.411, 95% 
CI 0.256–0.659), relative exclusion criteria for IVT alone 
(OR: 0.273, 95% CI 0.202–0.369; adjusted OR: 0.256, 95% 
CI 0.180–0.364), and non-exclusion criteria for IVT (OR: 
0.305, 95% CI 0.214–0.434; adjusted OR: 0.341, 95% CI 
0.226–0.514) (Supplemental Table 5). In patients with successful recanalization, we found no signifcant 
diference 
on 3-month favorable functional outcome between the presence of absolute exclusion criteria for IVT alone 
and relative 
exclusion criteria for IVT alone (reference) (OR: 0.672, 95% 
CI 0.289–1.564, p=0.356), between the presence of absolute exclusion criteria for IVT alone and non-
exclusion criteria for IVT (reference) (OR: 0.586, 95% CI 0.245–1.403, 
p=0.230), and between the presence of relative exclusion 
criteria for IVT alone and non-exclusion criteria for IVT 
(reference) (OR: 0.948, 95% CI 0.478–1.881, p=0.878),  
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Table 1 Demographics and clinical characteristics of the patients with and without absolute exclusion 
criteria for IVT 
Data are n (%) or median (IQR). Numbers within square brackets indicate number of missing values 
Absolute exclusion criteria for IVT p value 
Yes (n=870) No (n=1412) 
Demographics 
 Age (years), median (IQR) 74 (63–80) 73 (61–79) 0.033 
 Male sex, n (%) 428 (49.2) 731 (51.8) 0.245 
Years 
 2016–2017, n (%) 500 (57.5) 700 (49.6) <0.001 
Medical history 
 Hypertension, n (%) 488 (61.9) [82] 722 (64.5) [293] 0.247 
 Diabetes mellitus, n (%) 157 (19.9) [82] 215 (19.2) [293] 0.725 
 Hyperlipidemia, n (%) 174 (22.1) [82] 312 (27.9) [293] 0.005 
 Smoke habit, n (%) 126 (16) [82] 229 (20.5) [293] 0.014 
 Previous stroke/transient ischemic attack, n (%) 51 (6.5) [82] 89 (8) [293] 0.247 
 Atrial fbrillation, n (%) 414 (52.5) [82] 314 (28.1) [293] <0.001 
 Coronary heart disease, n (%) 100 (12.7) [82] 121 (10.8) [293] 0.217 
 Congestive heart failure, n (%) 94 (11.9) [82] 85 (7.6) [293] 0.002 
 Antiplatelet treatment, n (%) 191 (22) 430 (30.5) <0.001 
 Oral anticoagulant treatment, n (%) 371 (42.6) 79 (5.6) <0.001 
 Statin treatment, n (%) 128 (14.7) 199 (14.1) 0.712 
Baseline data 
 Pre-stroke mRS score≤1, n (%) 602 (80.3) [120] 1037 (84.9) [190] 0.009 
 NIHSS score, median (IQR) 18 (14–22) [48] 18 (13–21) [94] 0.090 
 ASPECT score≥6, n (%) 626 (96) [218] 1050 (95.6) [314] 0.806 
 Occlusion site <0.001 
  Tandem, n (%) 80 (9.2) [5] 219 (15.6) [12] 
  Intra-cranial internal carotid artery, n (%) 165 (19.1) [5] 274 (19.6) [12] 
  M1-segment middle cerebral artery, n (%) 386 (44.6) [5] 563 (40.2) [12] 
  M2-segment middle cerebral artery, n (%) 95 (11) [5] 122 (8.7) [12] 
  Vertebro-basilar arteries, n (%) 139 (16.1) [5] 222 (15.9) [12] 
 Good collateral circulation, n (%) 262 (73) [511] 360 (68.8) [889] 0.201 
 Relative exclusion criteria for IVT, n (%) 384 (44.1) 777 (55) <0.001 
 Non-exclusion criteria for IVT, n (%) – 635 (45) NA 
 Symptom onset-to-groin puncture time (min), median (IQR) 250 (185–341) 230 (171–300) <0.001 
  Type of procedure 0.576 
  Aspiration alone, n (%) 252 (40.4) [247] 387 (37.9) [391] 
  Stent retriever alone, n (%) 268 (43) [247] 462 (45.2) [391] 
  Combination of aspiration and stent retriever, n (%) 103 (16.5) [247] 172 (16.8) [391] 
  Additional IA fbrinolysis, n (%) 69 (7.9) 172 (12.2) 0.001 
  General anesthesia, n (%) 328 (45.1) [142] 613 (50) [186] 0.035 
 Procedure time (min), median (IQR) 70 (45–105) [16] 75 (50–110) [42] 0.016 
Radiological outcome measures 
 Any ICH, n (%) 191 (23.1) [43] 320 (24.2) [90] 0.567 
 PH, n (%) 75 (9.1) [43] 123 (9.3) [90] 0.878 
 Successful reperfusion (TICI 2b/3), n (%) 624 (72) [10] 1055 (75.6) [17] 0.112 
 Complete reperfusion (TICI 3), n (%) 488 (56.7) [10] 795 (57) [17] 0.930 
Functional outcome measures 
 3-Month mRS score 0–2, n (%) 316 (38.3) [46] 567 (43.2) [99] 0.027 
 3-Month death, n (%) 227 (27.5) [46] 262 (20) [99] <0.001 
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after adjustment for pre-defned variables of \model 2 (age, 
sex, pre-stroke mRS≤1, NIHSS score, LVO in the anterior 
circulation, symptom onset-to-groin puncture time, and procedure time). 
The causes of death in the entire cohort were sICH in 
98 (20%) patients, unsuccessful recanalization in 132 (27%) 
patients, systemic causes (i.e., sepsis, acute renal failure, 
status epilepticus, advanced cancer, pulmonary embolism, 
acute myocardial infarction, intestinal infarction, extra-cranial hemorrhage, or hematological disease) in 66 
(13.5%) 
patients, and unknown or unavailable causes in 193 (39.5%) 
patients (Supplemental Table 6). After adjustment for diferences in baseline characteristics variables 
between groups of 
patients with and without absolute exclusion criteria for IVT, 
ORs for death related to symptomatic ICH (sICH, 0.711, 
95% CI 0.337–1.498), death related to index stroke with 
unsuccessful recanalization (0.969, 95% CI 0.523–1.796), 
and death related to unknown or unavailable causes (0.831, 
95% CI 0.474–1.454) were not diferent between the groups, 
while OR for death related to systemic causes (2.294, 95% 
CI 1.058–4.973) was higher in patients with absolute exclusion criteria for IVT (Supplemental Table 6). 
In the entire cohort, association of single absolute exclusion criterion for IVT with intracerebral bleedings, 
recanalization, and functional outcomes are provided in Supplemental Tables 7, 8, and 9. After adjustment 
for pre-defned 
variables of model 2 (age, sex, pre-stroke mRS≤1, NIHSS 
score, LVO in the anterior circulation, symptom onsetto-groin puncture time, and procedure time), OR for 
PH 
was higher in patients with platelet count<100,000/mm3 
(OR: 3.201, 95% CI 1.149–8.916; p=0.026) (Supplemental Table 7), OR for successful recanalization was 
lower 
in patients with ulcer disease of the gastrointestinal tract 
in the last 3 months (OR: 0.283, 95% CI 0.083–0.959; 
p = 0.043) (Supplemental Table  8), and OR for favorable functional outcome was lower in patients with 
neoplasm with increased hemorrhagic risk (OR: 0.292, 95% 
CI 0.138–0.616; p=0.001) (Supplemental Table 9). ORs 
for death were higher in patients with administration 
of IV heparin in the previous 48 h with partial thromboplastin time (aPTT) (OR: 2.077, 95% CI 1.176–3.668; 
p=0.012), platelet count<100,000/mm3 
 (OR: 4.798, 95% 
CI 1.905–12.086; p=0.001), bacterial endocarditis or pericarditis (OR: 15.069, 95% CI 2.244–101.179; p 
=0.005), 
neoplasm with increased hemorrhagic risk (OR: 6.046, 95% 
CI: 3.338–10.950; p<0.001), and severe liver disease (OR: 
6.124, 95% CI 1.077–34.922; p = 0.041) (Supplemental 
Table 9). 
Additional results in the subgroups of the entire cohort 
are provided in Supplement Data. 
Discussion 
Our study showed that the presence of absolute exclusion 
criteria for IVT alone (vs relative absolute exclusion for 
IVT alone and vs non-exclusion criteria for IVT) in patients 
treated with direct mechanical thrombectomy did not afect 
the radiological outcome measures; ORs for death was 
higher in patients with absolute exclusion criteria for IVT 
alone after adjustment for unbalanced variables (model 1) 
and predefned variables (model 2), whereas no diference 
was observed on 3-month functional outcome among the 
groups. Among the groups, efect of successful recanalization on 3-month mRS was similar, and no 
signifcant diference on 3-month functional favorable outcome in patients 
with successful recanalization. As to causes of death, ORs 
for death related to symptomatic ICH or unsuccessful recanalization were similar among patients with and 
without 
absolute exclusion criteria for IVT, while OR for systemic 
causes of death, mainly related to complications of the conditions reported as absolute exclusion criteria 
for IVT, was 
higher in this group of patients. 
About 62% of patients of the entire cohort have relative 
exclusion criteria for IVT alone (34%) patients or non-exclusion criteria for IVT (28%), and hence were 
candidates to 
IVT. Although our data come from patients having exclusively LVO-related stroke, they are in line with a 
recent 
study that reported a gap between eligibility to IVT (defned 
Table 2 Absolute exclusion criteria for IVT 
Data are n (%) or median (IQR) 
a 
The “symptom onset>4.5  h” group included strokes with known 
symptom onset>4.5  h from endovascular treatment hospital admission, unknown onset strokes and wake-
up strokes with symptom recognition time or awakening time>4.5 h from endovascular treatment 
hospital admission 
N (%) 
Oral anticoagulant with INR>1.7 or DOAC 343 (15) 
Symptom onset>4.5 ha 323 (14.3) 
Recent administration of IV heparin 94 (4.1) 
Neoplasm with increased hemorrhagic risk 69 (3) 
current or recent severe bleeding 33 (1.4) 
Platelet count<100,000/mm3 26 (1.1) 
Known hemorrhagic diathesis 17 (0.7) 
Ulcer disease of the gastrointestinal tract (<3 months) 15 (0.7) 
Traumatic external heart massage or puncture of noncompressible blood vessel (<10 days) 
12 (0.5) 
Severe liver disease 10 (0.4) 
Intracranial hemorrhage on brain CT 8 (0.4) 
Bacterial endocarditis 7 (0.3) 
Suspicion of subarachnoid hemorrhage despite normal 
CT 
4 (0.2) 
Acute pancreatitis 3 (0.1) 
Hemorrhagic retinopathy 3 (0.1) 
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Table 3 Demographics and clinical characteristics of the patients with absolute exclusion criteria for IVT 
alone, relative exclusion criteria for 
IVT alone, and non-exclusion criteria for IVT alone 
Absolute exclusion 
criteria for IVT alone 
(n=486) 
Relative exclusion 
criteria for IVT alone 
(n=777) 
Non-exclusion criteria 
for IVT alone (n=635) 
*p value **p value ***p value 
Demographics 
 Age (years), median (IQR) 72 (61–79) 72 (62–79) 72 (61–80) 0.999 0.814 0.630 
 Male sex, n (%) 236 (48.6) 407 (52.4) 324 (51) 0.203 0.434 0.784 
Years 
 2016–2017, n (%) 288 (59.3) 389 (50.1) 311 (49) 0.001 0.001 0.708 
Medical history 
 Hypertension, n (%) 260 (60.7) [60] 437 (65.4) [109] 285 (63.2) [184] 0.123 0.487 0.446 
 Diabetes mellitus, n (%) 89 (20.8) [60] 133 (19.9) [109] 82 (18.2) [184] 0.758 0.349 0.487 
 Hyperlipidemia, n (%) 105 (24.5) [60] 193 (28.9) [109] 119 (26.4) [184] 0.126 0.537 0.377 
 Smoke habit, n (%) 70 (16.4) [60] 136 (20.4) [109] 93 (20.6) [184] 0.113 0.118 0.940 
 Previous stroke/transient 
ischemic attack, n (%) 
22 (5.1) [60] 69 (10.3) [109] 20 (4.4) [184] 0.002 0.639 <0.001 
 Atrial fbrillation, n (%) 215 (50.2) [60] 183 (27.4) [109] 131 (29) [184] <0.001 <0.001 0.587 
 Coronary heart disease, n 
(%) 
58 (13.6) [60] 71 (10.6) [109] 50 (11.1) [184] 0.150 0.304 0.845 
 Congestive heart failure, n 
(%) 
47 (11) [60] 53 (7.9) [109] 32 (7.1) [184] 0.106 0.046 0.647 
 Antiplatelet treatment, n (%) 93 (19.1) 275 (35.4) 155 (24.4) <0.001 0.036 <0.001 
 Oral anticoagulant treatment, 
n (%) 
178 (36.6) 42 (5.4) 0 <0.001 <0.001 0.907 
 Statin treatment, n (%) 79 (16.3) 136 (17.5) 63 (9.9) 0.591 0.002 <0.001 
Baseline data 
 Pre-stroke mRS score≤1, 
n (%) 
330 (80.9) [78] 578 (85.1) [98] 459 (84.5) [92] 0.076 0.140 0.810 
 NIHSS score, median (IQR) 17 (13–21) [23] 18 (13–22) [43] 17 (12–20) [51] 0.008 0.047 <0.001 
 ASPECT score≥6, n (%) 347 (95.1) [121] 575 (94.7) [170] 475 (96.1) [144] 0.882 0.221 0.137 
 Occlusion site 0.053 0.004 0.140 
  Tandem, n (%) 47 (9.7) [1] 115 (15) [9] 104 (16.5) [3] 
  Intra-cranial internal 
carotid artery, n (%) 
98 (20.2) [1] 136 (17.7) [9] 138 (21.8) [3] 
  M1-segment middle cerebral artery, n (%) 
216 (44.5) [1] 314 (40.9) [9] 249 (39.4) [3] 
  M2-segment middle cerebral artery, n (%) 
53 (10.9) [1] 76 (9.9) [9] 46 (7.6) [3] 
  Vertebro-basilar arteries, 
n (%) 
71 (14.6) [1] 127 (16.5) [9] 95 (15) [3] 
 Good collateral circulation, 
n (%) 
141 (75.4) [299] 217 (66) [448] 143 (73.7) [441] 0.029 0.725 0.078 
 Symptom onset-to-groin 
puncture time (min), 
median (IQR) 
255 (185–350) 240 (180–320) 230 (170–296) 0.035 <0.001 0.005 
 Type of procedure 0.526 0.900 0.264 
  Aspiration alone, n (%) 139 (39.5) [134] 206 (36.4) [111] 181 (39.8) [180] 
  Stent retriever alone, n (%) 154 (43.8) [134] 269 (47.5) [111] 193 (42.4) [180] 
  Combination of aspiration 
and stent retriever, n (%) 
59 (16.8) [134] 91 (16.1) [111] 81 (17.8) [180] 
 Additional IA fbrinolysis, 
n (%) 
39 (8) 99 (12.7) 73 (11.5) 0.009 0.057 0.513 
 General anesthesia, n (%) 175 (44.3) [91] 359 (52.3) [90] 254 (47.1) [96] 0.014 0.425 0.084 
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by the absence of absolute exclusion criteria) and reality in 
ischemic stroke patients admitted to the Stroke Units of the 
Veneto region of Italy during a period of 12 weeks from 
September 18th to December 10th, 2017 [16]; only 46% 
of the potentially eligible patients were actually treated 
with IVT [16]. Therefore, most patients appear to be inappropriately deprived of bridging therapy in favor 
of direct 
thrombectomy. 
Among the absolute exclusion criteria for IVT, patients 
with platelet count<100,000/mm3 
 had higher OR for PH, 
and patients with neoplasm with increased hemorrhagic risk 
had lower OR for favorable functional outcome; patients with 
recent administration of IV heparin, platelet count<100,000/ 
mm3 
, bacterial endocarditis, neoplasm with increased hemorrhagic risk, and severe liver disease had higher ORs 
for death 
after adjustment for predefned predictors. To date, only a few 
observational studies assessed safety and efcacy of mechanical thrombectomy in the presence of a single 
absolute exclusion criterion for IVT [17–21]. Published data are in line with 
our results regarding thrombocytopenia [17, 18], active cancer, 
and [19, 20] recent administration of IV heparin [21]. The 
association between these absolute exclusion criteria for IVT 
and increase of mortality was presumably related to an apparent poor pre-stroke health status such as the 
high frequency of 
associated ongoing sepsis, recent surgery, myocardial infarction, renal disease, and other systemic 
complications. Also, 
it is known that stroke is in itself a predictor of mortality in 
patients with infective endocarditis [22] due to fatal complications such as meningitis and brain abscesses, 
while liver 
disease is in itself associated with an increased risk of death 
after ischemic stroke [23]. 
Our study has some limitations. First, the present study did 
not randomize patients by treatment, but it is based on a retrospective analysis of prospectively collected 
data. Second, the 
number of missing data for outcome measures and pre-defned 
variables might have infuenced the fnal outcome. Third, reasons for the treatment were not recorded; it is 
likely that these 
choices were infuenced by unmeasurable factors related to 
individual physician’s decision, which might have infuenced 
our key fndings. In particular, we have not systematically 
collected data of perfusion imaging for unwitnessed stroke, 
wake-up-stroke, and stroke with known symptom onset>6 h. 
Finally, we did not use data of collateral circulation because 
they were missing in more than half of the patients included 
in the analyses. 
Nevertheless, to the best of our knowledge, this is the frst 
study that systematically assessed whether there were diferences among absolute, relative, and non-
exclusion criteria for 
IVT on radiological and functional outcomes in the largest 
large real word cohort of patients treated with direct mechanical thrombectomy that has not undergone 
restrictive selection 
as regards age, pre-stroke mRS score, NIHSS score, site occlusion, ASPECT score, and time window for 
treatment. 
Data are n (%) or median (IQR). Numbers within square brackets indicate number of missing values 
*Absolute exclusion criteria for IVT alone vs relative exclusion criteria for IVT alone 
**Absolute exclusion criteria for IVT alone vs non-exclusion criteria for IVT alone 
***Relative exclusion criteria for IVT alone vs non-exclusion criteria for IVT alone 
Table 3 (continued) 
Absolute exclusion 
criteria for IVT alone 
(n=486) 
Relative exclusion 
criteria for IVT alone 
(n=777) 
Non-exclusion criteria 
for IVT alone (n=635) 
*p value **p value ***p value 
 Procedure time (min), 
median (IQR) 
70 (45–100) [11] 75 (50–110) [] 75 (50–108) [37] 0.005 0.045 0.430 
Radiological outcome measures 
 Any ICH, n (%) 112 (24.3) [27] 187 (25.7) [50] 133 (22.4) [40] 0.631 0.463 0.156 
 PH, n (%) 44 (9.5) [27] 71 (9.8) [50] 52 (8.7) [40] 0.920 0.667 0.568 
 Successful reperfusion (TICI 
2b/3), n (%) 
365 (76) [6] 574 (74.5) [7] 481 (77) [10] 0.591 0.721 0.316 
 Complete reperfusion (TICI 
3), n (%) 
287 (59.8) [6] 424 (55.1) [7] 371 (59.4) [10] 0.113 0.902 0.115 
Functional outcome measures 
 3-Month mRS score 0–2, 
n (%) 
196 (42.6) [26] 316 (43.2) [45] 251 (43.4) [56] 0.857 0.850 0.955 
 3-Month death, n (%) 115 (25) [26] 154 (21) [45] 108 (18.7) n[56] 0.118 0.015 0.297 
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Conclusion 
Radiological outcomes were similar after direct thrombectomy in patients with absolute, relative, and non-
exclusion 
criteria for IVT, while an increase of fatal outcome was 
observed in the presence of some current absolute exclusion 
criterion for IVT. However, death related to sICH and unsuccessful recanalization was similar between the 
presence and 
absence of absolute exclusion criteria for IVT, while patients 
with absolute exclusion criteria for IVT had an increase of 
death due to systemic causes, usually as complications of the 
conditions classifed as absolute exclusion criteria for IVT. 
Our data support the use of mechanical thrombectomy in 
patients with absolute exclusion criterion for IVT. However, 
future randomized trials are needed to confrm our fndings. 
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